Multiple Sclerosis
Conference Coverage
Rapid Foot-Tapping Task Distinguishes Between MS Subtypes
NASHVILLE—A rapid foot-tapping task can distinguish between healthy controls and people with multiple sclerosis (MS), as well as...
Conference Coverage
Value of alemtuzumab demonstrated in RRMS patients with prior IFNB-1a treatment
CARE-MS II extension data suggest that alemtuzumab provides a unique treatment approach for relapsing-remitting multiple sclerosis patients with...
Video
Research on exercise in MS needs to build up some muscle
Researchers hope to increase the number of studies on cognitive rehabilitation and exercise in MS, just as has happened recently to rehab in...
Video
Pediatric MS gets a win with fingolimod
NASHVILLE, TENN. – First successful phase 3 study in pediatric MS may lead to a reshaping of the pediatric MS treatment paradigm.
Conference Coverage
Genetic Variations in the CYP2J2 Region May Be Associated With MS Risk
NASHVILLE—Single-nucleotide polymorphisms (SNPs) in the CYP2J2 region of chromosome 1 may be associated with an...
Video
Inside the complex, surprising world of MS comorbidities
Research suggests some conditions are more common in MS. Cancer is an outlier: Its rates may actually be lower than in the general population.
Video
Value-based care spawns new challenges for MS physicians
NASHVILLE, TENN. – Quality measures for MS aren’t designed to address patient needs, an advocate says, and cost issues spell more trouble.
Video
iPad app puts cognitive screening in the hands of MS patients
The Multiple Sclerosis Performance Test app attempts to sidestep the problem of time and manpower in administering cognitive screening.
Conference Coverage
AAN Publishes Practice Guideline on DMTs for MS
LOS ANGELES—Clinicians must engage in an ongoing dialogue with patients with multiple sclerosis (MS) regarding treatment decisions throughout the...
Conference Coverage
Do Cardiovascular Risk Factors Contribute to Brain Atrophy in MS?
LOS ANGELES—Hypertension and heart disease may contribute to advanced central and white matter atrophy in patients with multiple sclerosis (MS)...
Conference Coverage
Interim Results Show Efficacy for a Novel MS Drug
LOS ANGELES—Preliminary results for annualized relapse rate and MRI parameters support ALKS 8700 (also known as BIIB098) as an oral treatment for...